Sapir Lifshiz-Simon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sapir Lifshiz-Simon has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Yeshayahu Talmon
Department of Chemical Engineering and the Russell Berrie Nanotechnology Institute (RBNI), Technion-Israel Institute of Technology, Haifa 3200003, Israel
2 shared publications - Burcu Okmen Altas
Department of Chemical Engineering Hacettepe University Ankara Türkiye
1 shared publication - Gokce Dicle Kalaycioglu
Department of Chemical Engineering, Hacettepe University, Beytepe, 06800 Ankara, Turkey
1 shared publication - Nihal Aydogan
Department of Chemical Engineering Hacettepe University Ankara Türkiye
1 shared publication Thomas Zemb
Institute for Separation Chemistry ICSM, CEA, CNRS, University of Montpellier, ENSCM, Marcoule 30207, France
1 shared publicationWerner Kunz
Institute of Physical and Theoretical Chemistry, University of Regensburg, Regensburg 93040, Germany
1 shared publication
Latest Publications
- 11 January 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 660, 177-191
Ion effects on co-existing pseudo-phases in aqueous surfactant solutions: cryo-TEM, rheometry, and quantification
- 11 January 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 660, 177-191
Ion effects on co-existing pseudo-phases in aqueous surfactant solutions: cryo-TEM, rheometry, and quantification
- 2 January 2024
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (2) , 633-650
Tadpole-Like Anisotropic Polymer/Lipid Janus Nanoparticles for Nose-to-Brain Drug Delivery: Importance of Geometry, Elasticity on Mucus-Penetration Ability
Asymmetric geometry (aspect ratio >1), moderate stiffness (i.e., semielasticity), large surface area, and low mucoadhesion of nanoparticles are the main features to reach the brain by penetrating across the nasal mucosa. Herein, a new application has been presented for the use of multifunctional Janus nanoparticles (JNPs) with controllable geometry and size as a nose-to-brain (N2B) delivery system by changing proportions of Precirol ATO 5 and polycaprolactone compartments and other operating conditions. To bring to light the N2B application of JNPs, the results are presented in comparison with polymer and solid lipid nanoparticles, which are frequently used in the literature regarding their biopharmaceutical aspects: mucoadhesion and permeability through the nasal mucosa. The morphology and geometry of JPs were observed via cryogenic-temperature transmission electron microscopy images, and their particle sizes were verified by dynamic light scattering, atomic force microscopy, and scanning electron microscopy. Although all NPs showed penetration across the mucus barrier, the best increase in penetration was observed with asymmetric and semielastic JNPs, which have low interaction ability with the mucus layer. This study presents a new and promising field of application for a multifunctional system suitable for N2B delivery, potentially benefiting the treatment of brain tumors and other central nervous system diseases.
- 2 January 2024
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (2) , 633-650
Tadpole-Like Anisotropic Polymer/Lipid Janus Nanoparticles for Nose-to-Brain Drug Delivery: Importance of Geometry, Elasticity on Mucus-Penetration Ability
Asymmetric geometry (aspect ratio >1), moderate stiffness (i.e., semielasticity), large surface area, and low mucoadhesion of nanoparticles are the main features to reach the brain by penetrating across the nasal mucosa. Herein, a new application has been presented for the use of multifunctional Janus nanoparticles (JNPs) with controllable geometry and size as a nose-to-brain (N2B) delivery system by changing proportions of Precirol ATO 5 and polycaprolactone compartments and other operating conditions. To bring to light the N2B application of JNPs, the results are presented in comparison with polymer and solid lipid nanoparticles, which are frequently used in the literature regarding their biopharmaceutical aspects: mucoadhesion and permeability through the nasal mucosa. The morphology and geometry of JPs were observed via cryogenic-temperature transmission electron microscopy images, and their particle sizes were verified by dynamic light scattering, atomic force microscopy, and scanning electron microscopy. Although all NPs showed penetration across the mucus barrier, the best increase in penetration was observed with asymmetric and semielastic JNPs, which have low interaction ability with the mucus layer. This study presents a new and promising field of application for a multifunctional system suitable for N2B delivery, potentially benefiting the treatment of brain tumors and other central nervous system diseases.